Immunosuppressive Therapy and Risk of COVID-19 Infection in Patients With Inflammatory Bowel Diseases

BACKGROUND: The effect of immunosuppressive treatment for immune-mediated diseases on risk of the novel coronavirus disease 2019 (COVID-19) has not been established. We aimed to define the effect of targeted biologic and immunomodulator therapy on risk of COVID-19 in a multi-institutional cohort of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Inflamm Bowel Dis
Autores principales: Burke, Kristin E, Kochar, Bharati, Allegretti, Jessica R, Winter, Rachel W, Lochhead, Paul, Khalili, Hamed, Colizzo, Francis P, Hamilton, Matthew J, Chan, Walter W, Ananthakrishnan, Ashwin N
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2020
Materias:
Original Research Articles - Clinical
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7665507/
https://ncbi.nlm.nih.gov/pubmed/33089863
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ibd/izaa278
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares